MARKET

TELO

TELO

Telomir Pharms
NASDAQ
1.200
+0.060
+5.26%
Opening 11:35 03/31 EDT
OPEN
1.180
PREV CLOSE
1.140
HIGH
1.210
LOW
1.161
VOLUME
52.80K
TURNOVER
--
52 WEEK HIGH
4.005
52 WEEK LOW
1.050
MARKET CAP
41.26M
P/E (TTM)
-3.6474
1D
5D
1M
3M
1Y
5Y
1D
Telomir Pharmaceuticals submits IND to FDA for Telomir-1 in TNBC
TipRanks · 3h ago
Telomir Pharmaceuticals Submits Investigational New Drug Application To FDA To Treat Advanced And Metastatic Triple-Negative Breast Cancer
Benzinga · 3h ago
TELOMIR PHARMACEUTICALS SUBMITS IND TO FDA FOR TELOMIR-1 (TELOMIR-ZN) IN ADVANCED AND METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Reuters · 4h ago
Weekly Report: what happened at TELO last week (0323-0327)?
Weekly Report · 1d ago
Telomir Shareholders Approve Equity Plan and Bylaw Changes
TipRanks · 3d ago
Telomir Pharmaceuticals held its annual stockholders meeting; shares outstanding totaled 34.4 million
Reuters · 3d ago
Weekly Report: what happened at TELO last week (0316-0320)?
Weekly Report · 03/23 09:14
Weekly Report: what happened at TELO last week (0309-0313)?
Weekly Report · 03/16 09:14
More
About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company is focused on the development of Telomir-1, a novel small molecule metal ion chelator and regulator designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Telomir 1 is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal. Telomir-1 helps protect against age-related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease (a genetic disorder leading to toxic copper buildup in the body), and age-related macular degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer’s disease. It is exploring the potential of Telomir-1 with ongoing research in animals and then in humans. It is focused on developing and commercializing TELOMIR-1, proposed to be dosed orally, with the aim of promoting longevity and enhancing overall quality of life.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.